Delivery Order SPE2DB22D3301-SPE2DB26FX4AG
- Not listed
- The Defense Logistics Agency awarded a $14,061.54 delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Tezspire 210 mg/1.91 mL syringes. This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The work will be performed at the contractor's corporate office location in...
- The Defense Logistics Agency awarded a $4,687.18 delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Tezspire 210 mg/1.91 ml pen injectables. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion deadline of August 28, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order is a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Tezspire 210 mg/1.91 mL syringes valued at $2,343.59, with an ultimate completion date of October 1, 2025. This non-competitive delivery order utilizes firm fixed price pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026....
- The Defense Logistics Agency awarded a $46.87K delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Tezspire 210 mg/1.91 ml syringes. This non-competitive, firm fixed-price delivery order is set to be completed by October 6, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99M...
- The Defense Logistics Agency awarded a $28,123.08 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Tezspire 210 mg/1.91 mL syringes. The contract, which is non-set-aside and competitively awarded, has an ultimate completion date of October 14, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete purchase under a larger procurement vehicle...
- The Defense Logistics Agency awarded a $23,435.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Tezspire 210 mg/1.91 mL syringes on August 15, 2025, with an ultimate completion date of September 8, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical will be delivered to the company's...
- AmerisourceBergen Drug Corp has been awarded a delivery order by the Defense Logistics Agency (DLA) valued at $14,061.54 for the supply of Tezspire 210 mg/1.91 ml syringes. This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by October 1, 2025. The award was issued on September 10, 2025, with performance to occur at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Tezspire 210 mg/1.91 mL syringes with a ceiling value of $7,030.77. This is a firm fixed price delivery order with no set-aside designation, indicating the award was competitively procured. The contract is scheduled for ultimate completion by September 17, 2025, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $2,343.59 firm fixed price delivery order to AmerisourceBergen Drug Corp for Tezspire 210 mg/1.91 mL pen auto-injectors on August 11, 2025, with completion targeted for September 2, 2025. This is a non-set-aside, competitively awarded contract under which AmerisourceBergen will deliver the specified pharmaceutical product to support federal medical supply needs. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $4.7K delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Tezspire 210 mg/1.91 mL pen injections. This competitively awarded, firm fixed-price contract carries an ultimate completion date of September 29, 2025, and will be fulfilled at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB26FX4AGDelivery Order
The Defense Logistics Agency awarded a $14,061.54 delivery order to AmerisourceBergen Drug Corp for Tezspire 210 mg/1.91 mL syringes on October 29, 2025, with a completion date of November 20, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The pharmaceutical product will be delivered to the company's facility in Conshohocken, Pennsylvania, where the distributor maintains its corporate headquarters. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies an extensive range of medications and medical supplies to military and veteran healthcare systems. The company's $999.999 billion DLA prime contract serves as a comprehensive global pharmaceutical support vehicle enabling deliveries across multiple therapeutic domains to support Defense Health Agency operations and other federal healthcare customers worldwide. This specific delivery order for Tezspire, a biologic medication used in asthma treatment, exemplifies AmerisourceBergen's role in fulfilling specialized pharmaceutical needs for the federal healthcare enterprise through its established relationship with the Defense Logistics Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.1k | 10/29/25 |